Endocrine Pharmacology Flashcards
Describe the chemistry of levothyroxine (T4).
Affects DNA transcription and stimulates protein synthesis
List the important effects of Synthroid.
a. Promotes gluconeogenesis
b. Mobilizes glycogen stores
c. Increases basal metabolic rate
List three drugs used to treat hyperthyroidism.
a. Propylthiouracil
b. Iodides
c. Methimazol (Tapazole)
Describe the dental considerations of patients with thyroid disease.
a. Hypothyroid: cold, tired fatigued. More sensitive to CNS depressants so need lower dose sedatives and opiates.
b. Hyperthyroid: nervous, increased BP, may be sensitive to epinephrine (if active disease = absolute contraindication to epinephrine), palpitations and tachycardia, can perceive more pain, less sensitive to CNS depressants = may require higher dose pain meds
Name the drug used to treat Type I diabetes.
Insulin is the only effective drug to treat type 1
Describe how various preparations of insulin are characterized.
a. Classified 3 ways: onset, peak, duration of action
b. Short acting, rapid acting, intermediate acting, intermediate to long acting, long acting.
Identify several classes of oral drugs used to treat Type II diabetes.
a. Sulfonylureas – traditional
b. Biguanides (metaformin)
c. Alpha-glucosidase inhibitors
d. Thiazolidinediones (TZDs)
e. Incretins – GLP agonists, DDP-4 Inhibitors
Describe the mechanisms of action of sulfonylureas (oral hypoglycemic drugs) used to manage Type II diabetes.
Sulfonylureas: Promote insulin release from pancreatic beta cells, enhances effect of insulin to stimulate glucose uptake in muscle and fat cells.
Describe the mechanisms of action of biguanides (oral hypoglycemic) drugs used to manage Type II diabetes.
Biguanides: inhibits absorption of glucose from the gut, decreases liver glucose production, increases insulin sensitivity at the receptor sites and increases peripheral glucose uptake and utilization.
Describe the mechanisms of action of alpha-glucosidase inhibitors (oral hypoglycemic drugs) used to manage Type II diabetes.
Alpha-glucosidase inhibitors: inhibits the enzyme responsible for degrading complex carbohydrates in the gut. So no monosaccharides are made available for absorption after a meal. There is delay in blood glucose concentrations after a meal when on this drug.
Describe the mechanisms of action of thiazolidinediones (oral hypoglycemic drugs) used to manage Type II diabetes.
Thiazolidinediones: improves target cell response to insulin without increasing pancreatic insulin secretion. Resets insulin receptors = reduces insulin resistance. Depends on presence of insulin for activity. Decreases hepatic glucose output. Increases insulin stimulated glucose uptake in skeletal muscle and decreases lipolysis in adipocytes.
Describe the mechanisms of action of incretins (oral hypoglycemic drugs) used to manage Type II diabetes.
Incretins: mimic hormones produced by the body to stimulate release of insulin.
i. GLP-1 Receptor agonists: boosts insulin production by pancreas, slows absorption of food. Injectable! ii. DPP-4 inhibitors: blocks enzyme DPP-4 that breaks down GLP-1 peptide in gut.
Discuss the serious drug interaction associated with sulfonylurea drugs.
a. Administration of aspirin and sulfonylureas can enchance the hypoglycemic response. Aspirin displaces the sulfonylurea from plasma proteins causing increased blood levels of the sulfonylurea and can cause hypoglycemia.
b. Aspirin can also inhibit prostaglandin E synthesis. PGE inhibits glucose induced insulin secretion, so inhibition increases the insulin response and enhances the sulfonylureas = hypoglycemia
Discuss the A1C test and how it is used to assess glycemic control in patients with diabetes.
Glycated hemoglobin (HbA1c)= gold standard. Measures glycemic control for 6-12 weeks. Normal value 6.5%
Discuss common cardiovascular risks that occur in patients with diabetes.
a. Obsesity in diabetes increases the cardiovascular risks. b. Sulfonylureas are a drug used to treat diabetes, promote insulin release= increase cardiovascular mortality.
Describe the forms of estrogen in Premarin, Estratab, and Estraderm transdermal patch.
Premarin= conjugated equine estrogens, Estrab= esterfied estrogens, Estraderm transdermal patch= estradiol preps
Describe the rationale for use of Prempro.
Relieve symptoms of menopause, prevention of osteoporosis
Describe the results of the HERS study and the impact of the results on HRT use.
When on HRT saw cholesterol levels go down but they suffered increases in blood clots and no reduction of heart disease.
Describe the results of the Nurses Health Study study and the impact of the results on HRT use.
found that estrogen in combination with progestin may increase risk of stroke, this outwieghs long term use to prevent osteoporosis
Describe the results of the WHI study and the impact of the results on HRT use.
Didn’t see this in the notes.
Describe the most recent recommendations for use of HRT in terms of indications for use and duration of therapy.
short term use only= less than 5 years. Used to treat symptoms of menopause
Describe the mechanism of raloxifene (Evista)
activates estrogen receptors in bone
Describe the use for raloxifene (Evista)
prevention of osteoporosis in post menopausal women and breast cancer prevention